Search
Search
Close this search box.

Shock Supreme Court Ruling Invalidates New York’s Cannabis Advertising Restrictions

New York’s embattled cannabis regulators have taken another major hit this week after a shock Supreme Court ruling invalidated regulations regarding advertising.

On Thursday, an order issued by the Supreme Court of Albany County ruled that the strict marketing and advertising restrictions placed on cannabis businesses in the state ‘were arbitrary and capricious’.

With the long-criticised restrictions now deemed unconstitutional and vague by the court, dispensaries will now be able to advertise and fulfil orders on third-party platforms freely.

The case was brought against New York’s Office for Cannabis Management (OCM) and Cannabis Control Board (CCB) by online cannabis platform Leafly in September, alongside other petitioners.

It argued that restrictions on the ability to advertise products on third party platforms, use paid marketing, or share accurate pricing information violated its right to free speech.

The state reportedly failed to provide any evidence to support their reasoning behind these restrictions during the case.

Judge Kevin Bryant said: “There is nothing in the record to establish precisely how OCM developed the regulations, which staff members participated in the process, or how they addressed the litany of issues that were raised not only by petitioners but by other individuals who submitted comments.

“Given the absence of any evidence of the process by which these regulations were developed and approved, this Court must find that the conclusions were arbitrary and capricious and that there is no sound and substantial basis in the record to support the respondents actions.”

In response, the OCM told Green Market Report: “We are reviewing the decision and exploring all possible legal options.”

The damning ruling comes amid growing pressure on the state’s cannabis regulators, and is expected to open the door for further legal challenges to regulations in the coming months.

On Wednesday, it was initially thought that the court invalidated a major tranch of regulations sparking chaos among the already troubled nascent industry, but this was clarified and refined a day later to apply only to marketing restrictions.

⏰ Pre-order discount ends Jan 15
-- Days
-- Hours
-- Mins
Data packs delivered January 2026
🔬 New Report Due January 2026

Global Medical Cannabis Market Review 2026

A comprehensive analysis of the international medical cannabis supply chain — examining country-specific data on exports, imports, market size, domestic production, and distribution landscapes. Understand the driving forces behind global supply dynamics, the impact of telemedicine on patient access, and regulatory changes shaping the market.

What's covered

  • 📊 Global supply chain overview — understand export/import dynamics and domestic production capabilities
  • 🌍 8 export country snapshots — Canada, Portugal, Denmark, North Macedonia, Spain, Australia, Czech Republic, South Africa
  • 👥 6 patient market snapshots — Australia, Germany, UK, Poland, Brazil, France
  • 🔮 Key themes — Canada's global impact, telemedicine growth, new market openings, quota changes
Export Markets
🇨🇦 Canada 🇵🇹 Portugal 🇩🇰 Denmark 🇲🇰 N. Macedonia 🇪🇸 Spain 🇦🇺 Australia 🇨🇿 Czechia 🇿🇦 South Africa
Patient Markets
🇦🇺 Australia 🇩🇪 Germany 🇬🇧 UK 🇵🇱 Poland 🇧🇷 Brazil 🇫🇷 France
100% free • No credit card required
As trusted by
DIAGEO KPMG Coca-Cola BARCLAYS BNP PARIBAS AB InBev NOVARTIS Johnson & Johnson PEPSICO AXA POLITICO Bloomberg amazon CNN Business
Part of our annual market review series GDPR compliant

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?